Covered recipient · General Payments record
MICHELE L GARANT SMOTHERMAN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,709.70
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.57 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MILLICENT US INC | $68.22 | 4 |
| ABBVIE INC. | $55.43 | 2 |
| Astellas Pharma US Inc | $51.55 | 3 |
| PFIZER INC. | $35.66 | 2 |
| Hologic Sales and Service, LLC | $32.44 | 1 |
| Biogen, Inc. | $22.51 | 1 |
| Evofem Biosciences, Inc. | $21.65 | 1 |
| Aspira Women's Health Inc | $16.24 | 1 |
| Exeltis, USA Inc. | $15.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.78 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103772566 | CMS |
| ABBVIE INC. | $32.65 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103772568 | CMS |
| Aspira Women's Health Inc | $16.24 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126776715 | CMS |
| Astellas Pharma US Inc | $16.40 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139280148 | CMS |
| Astellas Pharma US Inc | $16.45 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139328932 | CMS |
| Astellas Pharma US Inc | $18.70 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139401821 | CMS |
| Biogen, Inc. | $22.51 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104808167 | CMS |
| Evofem Biosciences, Inc. | $21.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091286565 | CMS |
| Exeltis, USA Inc. | $15.87 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149993513 | CMS |
| Hologic Sales and Service, LLC | $32.44 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084868463 | CMS |
| MILLICENT US INC | $19.90 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907096 | CMS |
| MILLICENT US INC | $14.91 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907098 | CMS |
| MILLICENT US INC | $17.22 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907100 | CMS |
| MILLICENT US INC | $16.19 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150907102 | CMS |
| PFIZER INC. | $13.76 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131308770 | CMS |
| PFIZER INC. | $21.90 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.